A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study.
A double-blind placebo-controlled cross-over clinical trial of DONepezil in post-degenerative cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study